Liver diseases in children, often hereditary, present unique challenges, with conditions like biliary atresia, ...

Gastrointestinal cancers often develop silently but knowing risk factors and warning signs can lead to earlier detection and ...

The risk of dying from the most common form of primary liver cancer is approximately 30% higher for patients with low ...

The risk of dying from the most common form of primary liver cancer is about 30% higher for patients with low household ...

Berlin: Bayer has announced the initiation of a Phase I clinical trial with 225Ac-GPC3 (BAY 3547926), an investigational ...

There is no standard of care for fibrolamellar liver cancer, no targeted therapies. But that may be changing, thanks to ...

The company said that its test could overcome sensitivity issues with ultrasound and serum alpha-fetoprotein assays that are used to monitor at-risk patients.

Bayer has launched a first-in-human clinical trial for 225Ac-GPC3 (BAY 3547926), a novel targeted alpha radiopharmaceutical ...

LIVER CANCER, the third leading cause of cancer-related deaths globally, is primarily attributed to hepatocellular carcinoma ...

RT-PCR test quantifying CP mRNA in blood can detect hepatocellular carcinoma early—especially in AFP-negative cases—offering ...